Öffentliche Ausschreibungen icc hofmann - Ingenieurbüro für technische Informatik
Am Stockborn 16, 60439 Frankfurt/M, FRG
Tel.: +49 6082-910101 Fax.: +49 6082-910200
E-Mail: info@icc-hofmann.net
Öffentliche Ausschreibungen

Titel : DE-München - Unternehmens- und Managementberatung und zugehörige Dienste
Dokument-Nr. ( ID / ND ) : 2021022209113890557 / 90357-2021
Veröffentlicht :
22.02.2021
Angebotsabgabe bis :
20.03.2021
Dokumententyp : Ausschreibung
Vertragstyp : Dienstleistungsauftrag
Verfahrensart : Offenes Verfahren
Unterteilung des Auftrags : Gesamtangebot
Zuschlagkriterien : Wirtschaftlichstes Angebot
Produkt-Codes :
79400000 - Unternehmens- und Managementberatung und zugehörige Dienste
DE-München: Unternehmens- und Managementberatung und zugehörige Dienste

2021/S 36/2021 90357

Auftragsbekanntmachung

Dienstleistungen
Rechtsgrundlage:
Richtlinie 2014/24/EU

Abschnitt I: Öffentlicher Auftraggeber
I.1)Name und Adressen
Offizielle Bezeichnung: EIT Health e. V.
Postanschrift: Mies-van-der-Rohe-Str. 1 C
Ort: München
NUTS-Code: DE212 München, Kreisfreie Stadt
Postleitzahl: 80807
Land: Deutschland
E-Mail: [6]kseniia.choni@eithealth.eu
Internet-Adresse(n):
Hauptadresse: [7]www.eithealth.eu
I.3)Kommunikation
Die Auftragsunterlagen stehen für einen uneingeschränkten und
vollständigen direkten Zugang gebührenfrei zur Verfügung unter:
[8]https://www.dtvp.de/Satellite/notice/CXP4Y9PDV52/documents
Weitere Auskünfte erteilen/erteilt die oben genannten Kontaktstellen
Angebote oder Teilnahmeanträge sind einzureichen elektronisch via:
[9]https://www.dtvp.de/Satellite/notice/CXP4Y9PDV52
I.4)Art des öffentlichen Auftraggebers
Agentur/Amt auf regionaler oder lokaler Ebene
I.5)Haupttätigkeit(en)
Gesundheit

Abschnitt II: Gegenstand
II.1)Umfang der Beschaffung
II.1.1)Bezeichnung des Auftrags:

EIT Health DD Services 2021-23
Referenznummer der Bekanntmachung: EIT Health DD Services 2021-23
II.1.2)CPV-Code Hauptteil
79400000 Unternehmens- und Managementberatung und zugehörige Dienste
II.1.3)Art des Auftrags
Dienstleistungen
II.1.4)Kurze Beschreibung:

Due diligence and valuation analysis services.
II.1.5)Geschätzter Gesamtwert
Wert ohne MwSt.: 1.00 EUR
II.1.6)Angaben zu den Losen
Aufteilung des Auftrags in Lose: nein
II.2)Beschreibung
II.2.3)Erfüllungsort
NUTS-Code: DE212 München, Kreisfreie Stadt
II.2.4)Beschreibung der Beschaffung:

Apart from funding, EIT Health provides comprehensive support for
innovations that show the potential to have a positive impact on
healthcare. The ultimate goal is to transform promising ideas into
commercially viable products through a multi-disciplinary approach,
involving business, medicine, IT and other fields of knowledge.

EIT Health operates through recruiting collaborative projects to its
portfolio ([10]https://www.eithealth.eu/innovation_projects) by
publishing once a year a call for proposals in business creation,
Education and Innovation programmes. Only project consortia consisting
of EIT Health Partners (from 2 different European countries at least)
can apply.

In the call for proposals 2022 EIT Health for start-up driven
Innovation project, the start-up amplifier instrument is available. It
provides the opportunity for start-ups at the core of an innovation
project to benefit from extended funding of up to EUR 500 000 in
Innovation projects in return for an option to assume shares in the
start-up in the case of certain financial events. This instrument
contributes to EIT Health's sustainability strategy and makes EIT
Health a magnet for healthcare and life sciences start-ups in Europe
for the benefit of our partners.

In the evaluation process (please see Annex 3 for the overview of the
EIT Health's evaluation process), EIT Health will evaluate the proposal
itself (as it currently does) and the start-up through a due diligence
process. Both elements will be considered to define the level of
success of an innovation project. If start-up passes the due diligence
(none or minor issues identified during due diligence) it will be
considered for EIT funding as a part of an Innovation proposal. If
start-up does not pass the due diligence (major issues identified
during due diligence), Innovation proposal will not be considered for
EIT funding.

In parallel with due diligence, a valuation analysis should take place.
Valuation analysis should use the established methodologies and result
in the pre-money valuation number, that will be communicated to the
start-up before it presents Innovation proposal at the hearings.

Additionally, a start-up can select up to two milestones that allow
valuation increase during an innovation project duration (i. e. 3
years), given that the pre-defined milestones that significantly
de-risk the project/start-up are achieved. This is an optional offer
available to the funded start-ups. In case a start-up pursues this
offer, an additionally required valuation analysis will be performed
following the funding decision to define the valuation increase
associated with the timely achievement of milestone(s). The base
valuation and milestone-related valuation increase will be fixed at the
time of the signature of the option agreement between EIT Health and
start-up (prior to the project start).

Moreover, it is possible that the start-up is not incorporated at the
time of the call deadline and it will not be possible to perform due
diligence and valuation analysis for such start-up prior to the
hearings. In such cases, the due diligence and valuation analysis will
be performed after the start-up is incorporated (after 1 October 2021).

Finally, when start-up's valuation milestone(s) get achieved, the
review and validation of the milestone achievement will take place. The
clinical and technological validation will be performed by separately
contracted experts outside of the scope of this tender, however, from
the business side it will be required to review the start-up's business
plan and financials to ensure it follows its business plan in line with
the assumptions considered in the milestone-related valuation analysis.

To deliver these services, EIT Health seeks to engage a Service
Provider who will perform due diligence and valuation analysis for the
start-ups that as a part of an Innovation project with Start-up
Amplifier are invited to the hearings and/or funded through the call.

The following services are subject of the contract, in particular
within these tentative timeframes:

preparation work: between 26 April 2021-3 May 2021;

for the first wave of start-ups (between 15 and 30 start-ups):

valuation analysis: between 3 May 2021-18 May 2021;

due diligence: between 19 May 2021-4 June 2021.

milestone-related valuation analysis (between 3 and 6 start-ups,
sub-set of start-ups from the first wave): between 15 September 2021-30
September 2021;

for the second wave of start-ups (between 0 and 6 start-ups):

due Diligence: between 8 October 2021-15 October 2021;

valuation analysis: between 15 October 2021-22 October 2021;

milestone-revalue valuation analysis: between 22 October 2021-29
October 2021.

validation of the milestone achievement (business side): individual
timeline per each start-up's milestone plan, between 1 and 8
validations per year (in total).

In case of a contract renewal for the years 2022 and 2023, the timeline
and number of start-ups might deviate from the ones described above.
The tentative timeline and expected number of start-ups will be
communicated as a part of the extension confirmation.

The expected maximum number of the various types of services to be
provided per year will not exceed:

due diligence assessments: 36;

valuation analyses (including milestone-related valuation analyses):
48;

validations of milestone achievement: 80.
II.2.5)Zuschlagskriterien
Der Preis ist nicht das einzige Zuschlagskriterium; alle Kriterien sind
nur in den Beschaffungsunterlagen aufgeführt
II.2.6)Geschätzter Wert
Wert ohne MwSt.: 1.00 EUR
II.2.7)Laufzeit des Vertrags, der Rahmenvereinbarung oder des
dynamischen Beschaffungssystems
Beginn: 26/04/2021
Ende: 31/12/2021
Dieser Auftrag kann verlängert werden: ja
Beschreibung der Verlängerungen:

The duration of the contract will be from 26 April 2021 until 31
December 2021. EIT Health e. V. is entitled to unilaterally renew the
agreement twice, for 12 months each time, for up to two more Start-up
Amplifier programs in 2022 and 2023. The right is to be exercised at
the sole discretion of EIT Health e. V. and by written notice to the
Service Provider not later than 31 December 2021 (first renewal) and 31
December 2022 (second renewal).

EIT Health reserves the right to optionally award more valuation
analysis and/or due diligence services outside of the timeframe set out
above. Terms and conditions of the contract (including pricing) apply
accordingly.
II.2.10)Angaben über Varianten/Alternativangebote
Varianten/Alternativangebote sind zulässig: nein
II.2.11)Angaben zu Optionen
Optionen: ja
Beschreibung der Optionen:

See II.2.7).
II.2.13)Angaben zu Mitteln der Europäischen Union
Der Auftrag steht in Verbindung mit einem Vorhaben und/oder Programm,
das aus Mitteln der EU finanziert wird: ja
Projektnummer oder -referenz:

EIT Health Grant Agreement.
II.2.14)Zusätzliche Angaben

Abschnitt III: Rechtliche, wirtschaftliche, finanzielle und technische
Angaben
III.1)Teilnahmebedingungen
III.1.1)Befähigung zur Berufsausübung einschließlich Auflagen
hinsichtlich der Eintragung in einem Berufs- oder Handelsregister
Auflistung und kurze Beschreibung der Bedingungen:

1) Self-declaration (pursuant to Section 123 (1) to (3) GWB) that no
person whose conduct is attributable to the tenderer or a member of the
group of economic operators has been convicted, or a fine has been
legally established against the economic operator, pursuant to Section
30 OWiG, for an offense against:

Section 129 of the Criminal Code (Formation of Criminal
Associations), Section 129a of the Criminal Code (Formation of
Terrorist Associations) or Section 129b of the Criminal Code (Criminals
and Terrorist Associations Abroad);

Section 89c of the Criminal Code (Terrorist Financing) or the
participation in such an act or the provision or collection of
financial resources, having regard to the fact that these funds are
used or intended to be used in whole or in part to commit an offense
against Article 89a (2) (2) of the Criminal Code;

Section 261 of the Criminal Code (money laundering, concealment of
unlawfully acquired assets);

Section 263 of the Criminal Code (Fraud), in so far as the offense is
directed against the budget of the European Union or against households
managed by or on behalf of the European Union;

Article 264 of the Criminal Code (subsidy fraud), in so far as the
offense is directed against the budget of the European Union or against
households managed by or on behalf of the European Union;

Section 299 of the Criminal Code (corruption and bribery in business
dealings);

Section 108e of the Criminal Code (corruption and bribery of mandate
holders);

Sections 333 and 334 of the Criminal Code (Granting Benefit and
bribery) also in connection with § 335a of the Criminal Code (Foreign
and International Staff);

Article 2 (2) of the Law on Combating International Bribery (Bribery
of Foreign Members in International Business Transactions); or

Sections 232, 232a paragraphs 1 to 5, Sections 232b to 233a of the
Criminal Code (trafficking in human beings, forced prostitution, forced
labor, exploitation of labor, exploitation using a deprivation of
liberty).

Or the respective codes of the country of incorporation of the tenderer
or the members of the group of economic operators.

2) Self-declaration that the tenderer has fulfilled its obligation to
pay taxes, duties and social security contributions (§ 123 (4) GWB);

3) Self-declaration (on facultative exclusion grounds pursuant to § 124
GWB) that

neither the tenderer's company nor any person whose conduct is
attributable to the tenderer has failed to fulfill its obligations
under environmental, social or labor law when executing public
contracts;

the tenderer's company is not insolvent, insolvency proceedings or
similar proceedings have not been instituted or opened for the assets
of the tenderer's company, the opening of such proceedings has not been
refused for lack of assets, and the company is not in liquidation or
has ceased its activity;

neither the tenderer's company nor any person whose conduct is
attributable to the company has been guilty of grave professional
misconduct that calls into question the integrity of the company;

neither the company nor any person whose conduct is attributable to
the company has entered into agreements with other undertakings which
have the effect of preventing, restricting or distorting competition;

the entity has not materially or consistently fulfilled a material
breach in the execution of a previous public procurement or procurement
contract, resulting in termination, damages or similar legal
consequences.
III.1.2)Wirtschaftliche und finanzielle Leistungsfähigkeit
Auflistung und kurze Beschreibung der Eignungskriterien:

4) Either

proof (e. g. copy of insurance policy) of a professional civil
liability or errors and omissions insurance of the economic operator
with a minimum compensation limit of EUR 1 000 000.00 per claim and of
EUR 2 000 000.00 per year; or

self-declaration of the economic operator to contract the respective
insurance with this minimum compensation limits in case of award of the
contract.

In the case of a group of economic operators as tenderer, each member
has to submit this proof or self-declaration for its company.

5) Self-declaration of the total yearly turnover of the economic
operator and the turnover of the economic operator in the area of
services of similar nature and scope as set out in sections 2.3.1
2.3.3 of the procurement and procedure description, based on the last 3
fiscal years (2018 to 2020).

In the case of a group of economic operators as tenderer, the turnover
numbers of the members in each of the last 3 fiscal years are added up
for the fulfilment of the minimum requirement.
Möglicherweise geforderte Mindeststandards:

A minimum total yearly turnover of the economic operator of EUR 1 000
000.00 net of VAT in each of the last 3 fiscal years (2018 to 2020) is
required.
III.1.3)Technische und berufliche Leistungsfähigkeit
Auflistung und kurze Beschreibung der Eignungskriterien:

6) Self-declarations (according to the following requirements) of a
sufficient level of experience demonstrated by at least 2 reference
projects (minimum requirement) of services of similar nature and scope
as set out in sections 2.3.1 - 2.3.3 of the procurement and procedure
description and rendered in the past 3 years in the EU and preferably
also in other markets (i.e. Asia, USA), stating name, address and Email
address of a contact person of the contracting body of the reference
project and a project name and description of the services provided by
the tenderer. EIT Health reserves the right to verify the tenderer's
details.

In the case of groups of economic operators it must be clearly
indicated which reference project is assigned to which member. The
reference projects of the members fulfilling the minimum requirements
are attributed to the group of economic operators.
Möglicherweise geforderte Mindeststandards:

At least 2 reference projects (minimum requirement) of services of
similar nature and scope as set out in sections 2.3.1-2.3.3 of the of
the procurement and procedure description and rendered in the past 3
years in the EU and preferably also in other markets (i.e. Asia, USA),
is required.
III.2)Bedingungen für den Auftrag
III.2.3)Für die Ausführung des Auftrags verantwortliches Personal
Verpflichtung zur Angabe der Namen und beruflichen Qualifikationen der
Personen, die für die Ausführung des Auftrags verantwortlich sind

Abschnitt IV: Verfahren
IV.1)Beschreibung
IV.1.1)Verfahrensart
Offenes Verfahren
IV.1.3)Angaben zur Rahmenvereinbarung oder zum dynamischen
Beschaffungssystem
Die Bekanntmachung betrifft den Abschluss einer Rahmenvereinbarung
Rahmenvereinbarung mit einem einzigen Wirtschaftsteilnehmer
IV.1.8)Angaben zum Beschaffungsübereinkommen (GPA)
Der Auftrag fällt unter das Beschaffungsübereinkommen: ja
IV.2)Verwaltungsangaben
IV.2.2)Schlusstermin für den Eingang der Angebote oder Teilnahmeanträge
Tag: 20/03/2021
Ortszeit: 12:00
IV.2.3)Voraussichtlicher Tag der Absendung der Aufforderungen zur
Angebotsabgabe bzw. zur Teilnahme an ausgewählte Bewerber
IV.2.4)Sprache(n), in der (denen) Angebote oder Teilnahmeanträge
eingereicht werden können:
Englisch
IV.2.6)Bindefrist des Angebots
Laufzeit in Monaten: 2 (ab dem Schlusstermin für den Eingang der
Angebote)
IV.2.7)Bedingungen für die Öffnung der Angebote
Tag: 20/03/2021
Ortszeit: 12:00

Abschnitt VI: Weitere Angaben
VI.1)Angaben zur Wiederkehr des Auftrags
Dies ist ein wiederkehrender Auftrag: nein
VI.2)Angaben zu elektronischen Arbeitsabläufen
Aufträge werden elektronisch erteilt
VI.3)Zusätzliche Angaben:

Notices-ID: CXP4Y9PDV52
VI.4)Rechtsbehelfsverfahren/Nachprüfungsverfahren
VI.4.1)Zuständige Stelle für Rechtsbehelfs-/Nachprüfungsverfahren
Offizielle Bezeichnung: Regierung von Oberbayern - Vergabekammer
Südbayern
Postanschrift: Maximilianstraße 39
Ort: München
Postleitzahl: 80538
Land: Deutschland
E-Mail: [11]vergabekammer.suedbayern@reg-ob.bayern.de
Telefon: +49 8921762411
Fax: +49 8921762847
Internet-Adresse:
[12]www.regierung.oberbayern.bayern.de/behoerde/mittelinstanz/vergabeka
mmer
VI.4.3)Einlegung von Rechtsbehelfen
Genaue Angaben zu den Fristen für die Einlegung von Rechtsbehelfen:

The application for a review procedure at the review body as set out in
section VI.4.1) is inadmissible pursuant to § 160 (3) GWB if

1) The applicant has recognized the alleged infringement of public
procurement rules prior to the submission of the petition for review
and has not issued a complaint to EIT Health within a period of ten
calendar days;

2) Infringements of public procurement rules which are discernible on
the basis of the contract notice are not notified to EIT Health at the
latest by the expiry of the time limit specified in the contract notice
for the request to participate or the submission of tenders;

3) Infringements of procurement rules which are discernible on the
basis of the procurement documents are not notified to EIT Health at
the latest by the expiry of the time limit specified in the contract
notice for the request to participate or the submission of tenders;

4) More than 15 calendar days have elapsed after receipt of the
notification by EIT Health to not remedy a complaint of the tenderer.
VI.5)Tag der Absendung dieser Bekanntmachung:
17/02/2021

References

6. mailto:kseniia.choni@eithealth.eu?subject=TED
7. http://www.eithealth.eu/
8. https://www.dtvp.de/Satellite/notice/CXP4Y9PDV52/documents
9. https://www.dtvp.de/Satellite/notice/CXP4Y9PDV52
10. https://www.eithealth.eu/innovation_projects
11. mailto:vergabekammer.suedbayern@reg-ob.bayern.de?subject=TED
12. http://www.regierung.oberbayern.bayern.de/behoerde/mittelinstanz/vergabekammer

 
 
Ausschreibung ausschreibung Ausschreibungen Ingenieure Öffentliche Ausschreibungen Datenbank Öffentliche Ausschreibungen Architekten Öffentliche Ausschreibungen Bau